ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO066

Clinical Outcomes of Patients Admitted to the ICU with AKI in a Jordanian Tertiary Hospital

Session Information

  • AKI: Clinical Outcomes, Trials
    November 08, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 102 AKI: Clinical, Outcomes, and Trials

Authors

  • Oweis, Ashraf Omar, Jordan University Of Science and Technology, Amman, Jordan
  • Alshelleh, Sameeha A., The University Of Jordan, Amman, Jordan
Background

Despite advances in medical technologies, therapeutic options, acute kidney injury (AKI) still a major contriputor of death in intesive care units (ICU) regardless of renal replacment therapy used to treat severe AKI

Methods

We retrospectively reviewed electronic patients records for all patients admitted to our ICU.
We used acute kidney injury network (AKIN) classification to define and stage AKI, For continuous variables; mean, standard deviation, minimum and maximum were used, and for differences between normally distributed values we used unpaired t test. Percentages used for categorical variables. Pearson Chi- square test was used to test categorical variables. Univariate and multivariate regression analyses were performed to determine the independent predictors of AKI.

Results

We evaluated 1500 patient electronic records who were admitted to our ICU between 2014 -2015 with at least one year follow up.
Using univariate analysis age was predictor of AKI, Serum albumin at admission was a strong predictor of AKI, mean serum albumin for the AKI group 30.1 g/l (SD 9.4), and 33.5 g/l (SD 8.9) for the non AKI group, P=0.001, also admission Hb predicted AKI, mean Hb for the AKI was 10.9 (SD 3.1) vs. 11.4 (SD 2.9), P=0.0004. The incidence of AKI was 35.6%, most of them were with stage1 AKI. Mean serum creatinine was 150.7 mmol/l (SD 147.7) for patients with AKI vs. 118.2 mmol/l (SD 135.3) for the other group, P=0.001. Out of the patients who developed AKI, 52.2% (82 patients) started on dialysis for different reasons (Hyperkalemia 15%, fluid overload 46.6%, combination of both 38.4%). of whom 22 patients continued dialysis as outpatients.
Renal recovery (defined as return to baseline creatinine) at discharge was 17.2% (51 patients), Mortality by the time of discharge was 4.3% (62 patients).

Conclusion

AKI incidence in Jordan is comparable to worldwide incidence with significant effect on long term survival after discharge, correctable factors should be addressed to decrease incidence in the future.